Evaluation of Cardiovascular Risk Associated with SKI306X Use in Patients with Osteoarthritis and Rheumatoid Arthritis
Conclusions Evaluation of the cardiovascular safety of the anti-inflammatory analgesic herbal medicine SKI306X revealed that it did not differ from that of naproxen, which is known to have low cardiovascular risk. Graphical abstract
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Aleve | Arthritis | Cardiology | Cardiovascular | Celebrex | Complementary Medicine | Drugs & Pharmacology | Health Insurance | Heart | Herbs | Insurance | Naproxen | Osteoarthritis | Rheumatoid Arthritis | Rheumatology | Study